These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3115809)

  • 21. [Capreomycin, ethambutol and isoniazid in the original treatment of pulmonary tuberculosis].
    Rey JC; Pilheu J; Iannello J; González Montaner LJ
    Prensa Med Argent; 1967 Sep; 54(27):1375-6. PubMed ID: 5619888
    [No Abstract]   [Full Text] [Related]  

  • 22. Isoniazid plus ethambutol in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):272-5. PubMed ID: 5083435
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Toxic bilateral optic neuropathy caused by ethambutol and isoniazid].
    Furia M; Hamard H; Gérolami I
    Bull Soc Ophtalmol Fr; 1986 Dec; 86(12):1421-2. PubMed ID: 3581364
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intermittent 2-phase therapy using ethambutol-INH-streptomycin].
    Eule H; Fichtner K; Gross V; Sellau J
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):139-57. PubMed ID: 4627225
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperuricaemia induced by ethambutol.
    Narang RK; Agarwal MC; Raina AK; Singh SN; Bihari K; Sharma SN
    Br J Dis Chest; 1983 Oct; 77(4):403-6. PubMed ID: 6639867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 28. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optic disk tubercle.
    Mansour AM
    J Neuroophthalmol; 1998 Sep; 18(3):201-3. PubMed ID: 9736206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 32. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 33. [Importance of early performance of the Farnsworth test in the course of anti-tubercular therapy with ethambutol].
    Minutillo U; Severino R; Erpici M; Pezza A; Cotticelli L; Peccarino V
    Arch Monaldi; 1979; 34(1-2):70-82. PubMed ID: 554577
    [No Abstract]   [Full Text] [Related]  

  • 34. Optic neuropathy in ethambutol-treated renal tuberculosis.
    DeVita EG; Miao M; Sadun AA
    J Clin Neuroophthalmol; 1987 Jun; 7(2):77-86. PubMed ID: 2956288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ocular toxicity of ethambutol].
    Hermann P
    Annee Ther Clin Ophtalmol; 1971; 22():387-93. PubMed ID: 4127784
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ
    Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ethambutol--tolerance and side effects].
    Dücker I; Jungbluth H; Kropp R; Mitrou G; Stärk N
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 134(2):169-75. PubMed ID: 5206951
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vision impairment in the course of lung tuberculosis treatment].
    Sobota I; Czik T
    Acta Med Croatica; 2006; 60(2):181-4. PubMed ID: 16848215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.